Silver nanoparticles (AgNPs) possess strong antibacterial effect. The current trend is to incorporate AgNPs into functional materials that benefit from their bactericidal capabilities. Hydroxypropyl methylcellulose (HPMC) is routinely used for the controlled release of medicine thanks to its slow dissolution in water and could be used as a matrix for the controlled release of AgNPs, if a method to produce such a material without the need of other reactants was developed. We proposed such a method in a photochemical reduction of AgNO3 in hydroxypropyl methylcellulose (HPMC) solutions by the illumination of the mixture with the light emitting diode bulb for about 2 h. These AgNPs were characterized by transmission electron microscopy and their diameter was found to be mostly under 100 nm. The colloids were then easily transformed into solid samples by drying, lyophilization and spin-coating. The slowly soluble HPMC was found to be able to release the AgNPs gradually over the duration of several hours. Antibacterial activity of the prepared colloids and the solid samples was tested against Escherichia coli and Staphylococcus epidermidis and was found to be very high, reaching the total elimination of the bacteria in the studied systems.
28 November 2024 in International Journal of Pharmaceutics
Transforming poorly soluble active pharmaceutical ingredients (APIs) into a nanoparticulate form is a proven way of improving their dissolution characteristics. The preparation of API nanosuspensions is commonly achieved by wet-stirred media milling. The challenge lies in converting the nanosuspension into a solid dosage form without compromising its re-dispersibility. In the present work, an API nanosuspension was combined with additional excipients and used as abinder in fluid-bed granulation to obtain granules with systematically varying dissolution properties. Specifically, polymeric excipients (hydroxypropyl methylcellulose grade E5 and polyvinylpyrrolidone grade K30) were used in the nanosuspension binder to granulate microcrystalline cellulose or Pearlitol CR-H substrate. The resulting granules were used as feed material to prepare minitablets whose combination enabled the formation of multi-unit dosage form (MUDF) capsules with tuneable drug release profiles, paving the way to rational design and manufacturing of precision medicines.